An official website of the United States government
Home
Name
Alitretinoin
Alternate Names
None
Abbreviations
9cRA
Category
Differentiation inducing agent
Subcategory
None
NSC Number
659772
Primary Site
Histology
None
Remarks
Phase II (breast, sarcoma, skin) Phase III APL A natural retinoid with actions similar to all-trans-retinoic acid (tretinoin). FDA approved use for Kaposi's sarcoma. Ligand Pharamceuticals, Vical, NCI.
Coding
This drug should NOT be coded
